Status:

COMPLETED

SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting

Lead Sponsor:

Virginia Commonwealth University

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Parkinson Disease

Eligibility:

All Genders

18+ years

Brief Summary

People with Parkinson's disease (PD) may experience a walking problem called freezing of gait (FoG) that can interfere with the person's ability to conduct daily activities. FoG has been described as ...

Detailed Description

Usual care for PD involves taking medications to help with disease. In this study, participants will receive usual care. Participants will be asked to have taken their medication before they arrive, a...

Eligibility Criteria

Inclusion

  • Inclusion
  • age \>18 years,
  • Parkinson's disease (PD) diagnosed by a movement disorder specialist using UK Brain Bank criteria,
  • are able to walk independently or with a simple device (e.g., cane or walker), and
  • are observed by the research team to have PD-related FoG in at least two of the five previously described common trigger scenarios (i.e., freezing upon gait initiation, walking through tight quarters, freezing when changing directions, approaching a visual target, dual tasking, and stressful, time sensitive situations such as entering an elevator before the doors close).
  • Exclusion
  • individuals with known Parkinson plus syndrome,
  • presence of dementia (Montreal Cognitive Assessment \< 21),
  • an additional disorder (not related to PD) impairing gait,
  • history of implantable cardiac device or any other implanted electronic device except DBS,
  • peripheral neuropathy (determined by use of tuning fork to check for ability to feel vibration),
  • any condition that, in the opinion of the PI, would compromise participant safety, data integrity, or data interpretation,
  • pregnancy.

Exclusion

    Key Trial Info

    Start Date :

    June 11 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 10 2025

    Estimated Enrollment :

    12 Patients enrolled

    Trial Details

    Trial ID

    NCT04746846

    Start Date

    June 11 2021

    End Date

    March 10 2025

    Last Update

    August 22 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Virginia Commonwealth University

    Richmond, Virginia, United States, 23298